Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 65
SponsorUniversity of California, San Francisco

About this trial

Every year there are an estimated 230,000 childhood deaths from TB. There is an urgent need for novel tests for TB diagnosis in children under 15 years. The Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and the Assessing Diagnostics at Point-of-care for Tuberculosis in children (ADAPT for Kids) studies seek to reduce the burden of TB worldwide by evaluating faster, simpler, and less expensive TB triage and diagnostic tests for use in children.

Eligibility criteria

Qualifiers

Unexplained cough for any duration

TB contact or tuberculin skin test or interferon gamma release assay positive

Abnormal chest X-ray (any abnormality) OR

Unexplained weight loss OR unexplained failure to thrive OR Severe Acute Malnutrition

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Oral swab molecular testing
  • Automated Cough Sound Analysis
  • Automated Lung Sound Analysis
  • Chest X Ray Computer Aided Detection

Treatment groups

2,100 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

Instituto Nacional de Saúde, Mozambique

Collaborator

National Referral Hospital

Collaborator

University of Cape Town

Collaborator

Johns Hopkins University

Collaborator

Elizabeth Glaser Pediatric AIDS Foundation

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

University of California, Irvine

Collaborator